In heterogeneous catalysis, the catalyst is in a different phase from the reactants. SDS of cas: 152265-57-1, At least one of the reactants interacts with the solid surface in a physical process called adsorption in such a way. 152265-57-1, name is 7-Bromophthalazin-1(2H)-one. In an article£¬Which mentioned a new discovery about 152265-57-1
Discovery of Dihydrobenzoxazepinone (GS-6615) Late Sodium Current Inhibitor (Late INai), a Phase II Agent with Demonstrated Preclinical Anti-Ischemic and Antiarrhythmic Properties
Late sodium current (late INa) is enhanced during ischemia by reactive oxygen species (ROS) modifying the Nav 1.5 channel, resulting in incomplete inactivation. Compound 4 (GS-6615, eleclazine) a novel, potent, and selective inhibitor of late INa, is currently in clinical development for treatment of long QT-3 syndrome (LQT-3), hypertrophic cardiomyopathy (HCM), and ventricular tachycardia-ventricular fibrillation (VT-VF). We will describe structure-activity relationship (SAR) leading to the discovery of 4 that is vastly improved from the first generation late INa inhibitor 1 (ranolazine). Compound 4 was 42 times more potent than 1 in reducing ischemic burden in vivo (S-T segment elevation, 15 min left anteriorior descending, LAD, occlusion in rabbits) with EC50 values of 190 and 8000 nM, respectively. Compound 4 represents a new class of potent late INa inhibitors that will be useful in delineating the role of inhibitors of this current in the treatment of patients.
I hope this article can help some friends in scientific research. I am very proud of our efforts over the past few months and hope to 152265-57-1, help many people in the next few years.SDS of cas: 152265-57-1
Reference£º
Phthalazine – Wikipedia,
Phthalazine | C8H6N713 – PubChem